CIBC Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.4M | Sell |
136,785
-3,169
| -2% | -$265K | 0.03% | 363 |
|
|
2026
Q1 | $11.2M | Buy |
139,954
+2,136
| +2% | +$176K | 0.03% | 351 |
|
|
2025
Q4 | $11.7M | Buy |
137,818
+54,985
| +66% | +$4.51M | 0.03% | 339 |
|
|
2025
Q3 | $6.44M | Sell |
82,833
-190
| -0.2% | -$14.8K | 0.02% | 374 |
|
|
2025
Q2 | $6.49M | Sell |
83,023
-7,689
| -8% | -$573K | 0.02% | 373 |
|
|
2025
Q1 | $6.57M | Sell |
90,712
-2,715
| -3% | -$194K | 0.02% | 365 |
|
|
2024
Q4 | $6.92M | Sell |
93,427
-31,973
| -25% | -$2.24M | 0.02% | 355 |
|
|
2024
Q3 | $8.28M | Buy |
125,400
+7,749
| +7% | +$563K | 0.03% | 315 |
|
|
2024
Q2 | $10.9M | Sell |
117,651
-3,874
| -3% | -$343K | 0.04% | 249 |
|
|
2024
Q1 | $11.6M | Buy |
121,525
+6,550
| +6% | +$550K | 0.04% | 247 |
|
|
2023
Q4 | $8.77M | Buy |
114,975
+27,324
| +31% | +$1.9M | 0.03% | 278 |
|
|
2023
Q3 | $6.07M | Sell |
87,651
-2,357
| -3% | -$189K | 0.03% | 324 |
|
|
2023
Q2 | $8.49M | Sell |
90,008
-1,114
| -1% | -$96.8K | 0.03% | 273 |
|
|
2023
Q1 | $7.54M | Buy |
91,122
+1,417
| +2% | +$111K | 0.03% | 291 |
|
|
2022
Q4 | $6.69M | Buy |
89,705
+5,689
| +7% | +$438K | 0.03% | 304 |
|
|
2022
Q3 | $6.94M | Buy |
84,016
+6,862
| +9% | +$660K | 0.03% | 276 |
|
|
2022
Q2 | $7.34M | Buy |
77,154
+16,410
| +27% | +$1.7M | 0.03% | 259 |
|
|
2022
Q1 | $7.15M | Buy |
60,744
+634
| +1% | +$71.1K | 0.03% | 296 |
|
|
2021
Q4 | $7.79M | Buy |
60,110
+3,063
| +5% | +$357K | 0.03% | 296 |
|
|
2021
Q3 | $6.46M | Buy |
57,047
+1,635
| +3% | +$187K | 0.03% | 306 |
|
|
2021
Q2 | $5.74M | Buy |
55,412
+570
| +1% | +$53.7K | 0.02% | 327 |
|
|
2021
Q1 | $4.59M | Sell |
54,842
-613
| -1% | -$51.8K | 0.02% | 341 |
|
|
2020
Q4 | $5.06M | Sell |
55,455
-79
| -0.1% | -$6.55K | 0.02% | 310 |
|
|
2020
Q3 | $4.43M | Buy |
55,534
+1,008
| +2% | +$78.7K | 0.02% | 296 |
|
|
2020
Q2 | $3.77M | Buy |
54,526
+250
| +0.5% | +$17.8K | 0.02% | 296 |
|
|
2020
Q1 | $3.41M | Sell |
54,276
-1,569
| -3% | -$113K | 0.02% | 290 |
|
|
2019
Q4 | $4.34M | Sell |
55,845
-5,508
| -9% | -$430K | 0.02% | 282 |
|
|
2019
Q3 | $4.5M | Sell |
61,353
-47,706
| -44% | -$3.35M | 0.03% | 265 |
|
|
2019
Q2 | $6.72M | Buy |
109,059
+9,165
| +9% | +$554K | 0.04% | 196 |
|
|
2019
Q1 | $6.37M | Sell |
99,894
-819
| -0.8% | -$46.7K | 0.04% | 200 |
|
|
2018
Q4 | $5.14M | Buy |
100,713
+7,242
| +8% | +$366K | 0.04% | 190 |
|
|
2018
Q3 | $5.42M | Buy |
93,471
+15,699
| +20% | +$768K | 0.03% | 204 |
|
|
2018
Q2 | $3.77M | Buy |
77,772
+17,346
| +29% | +$810K | 0.02% | 272 |
|
|
2018
Q1 | $2.81M | Sell |
60,426
-2,991
| -5% | -$130K | 0.02% | 317 |
|
|
2017
Q4 | $2.38M | Sell |
63,417
-2,502
| -4% | -$91.8K | 0.01% | 371 |
|
|
2017
Q3 | $2.4M | Buy |
65,919
+657
| +1% | +$25.1K | 0.02% | 355 |
|
|
2017
Q2 | $2.57M | Buy |
65,262
+159
| +0.2% | +$5.8K | 0.02% | 341 |
|
|
2017
Q1 | $2.04M | Sell |
65,103
-2,457
| -4% | -$76.9K | 0.01% | 393 |
|
|
2016
Q4 | $2.11M | Buy |
67,560
+1,050
| +2% | +$34K | 0.02% | 377 |
|
|
2016
Q3 | $2.67M | Sell |
66,510
-5,202
| -7% | -$196K | 0.02% | 315 |
|
|
2016
Q2 | $2.38M | Buy |
71,712
+909
| +1% | +$31.1K | 0.02% | 333 |
|
|
2016
Q1 | $2.08M | Sell |
70,803
-2,994
| -4% | -$82.6K | 0.02% | 358 |
|
|
2015
Q4 | $1.94M | Sell |
73,797
-1,095
| -1% | -$28.4K | 0.02% | 368 |
|
|
2015
Q3 | $1.77M | Sell |
74,892
-1,296
| -2% | -$31.3K | 0.01% | 376 |
|
|
2015
Q2 | $1.81M | Buy |
76,188
+2,178
| +3% | +$49.2K | 0.01% | 398 |
|
|
2015
Q1 | $1.76M | Sell |
74,010
-36
| -0% | -$808 | 0.01% | 407 |
|
|
2014
Q4 | $1.57M | Sell |
74,046
-20,328
| -22% | -$408K | 0.01% | 419 |
|
|
2014
Q3 | $1.61M | Sell |
94,374
-870
| -0.9% | -$13.7K | 0.01% | 457 |
|
|
2014
Q2 | $1.36M | Sell |
95,244
-3,186
| -3% | -$43.2K | 0.01% | 509 |
|
|
2014
Q1 | $1.22M | Sell |
98,430
-1,554
| -2% | -$17.9K | 0.01% | 533 |
|
|
2013
Q4 | $1.1M | Buy |
99,984
+2,478
| +3% | +$27.9K | 0.01% | 536 |
|
|
2013
Q3 | $1.13M | Sell |
97,506
-1,038
| -1% | -$12.1K | 0.01% | 503 |
|
|
2013
Q2 | $1.1M | Buy |
+98,544
| New | +$1.17M | 0.01% | 494 |
|
Other funds holding EW
CIBC Asset Management's EW Position: Q2 2026 in Review
CIBC Asset Management reduced its Edwards Lifesciences (EW) stake by 2.3% in Q2 2026, selling an estimated $265K and leaving 136,785 shares worth $12.4M. The position accounts for 0.03% of the portfolio, ranked #363.
CIBC Asset Management first reported a position in EW in Q2 2013 and has held it in 53 quarters since. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- CIBC Asset Management held 136,785 shares of Edwards Lifesciences worth $12.4M as of Q2 2026.
- CIBC Asset Management sold 3,169 Edwards Lifesciences shares in Q2 2026, an estimated $265K.
- Edwards Lifesciences made up 0.03% of CIBC Asset Management's portfolio in Q2 2026, its #363 holding.
- CIBC Asset Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
- 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.